Close Menu

More articles about Cancer

The initiative, which began in 2005, now has 37 members.

Strands: Feb 26, 2009

Premium

Tekmira Pharmaceuticals, MDRNA

Vista has secured rights to the nanowire technology from Harvard and previous spinout Nanosys, which has, for the time being, eschewed biomedical applications for the tech in favor of nearer-term commercial opportunities.

The study suggests it is "unlikely" that patents protecting biomedical inventions "will ever be licensed" if they have remained unlicensed for more than eight years since their priority patent application was filed.

Imperial College London and its spinout DNA Electronics have created a prototype for the so-called SNP Dr., which is being developed under a £1.2 million project that also includes Pfizer.

The study findings suggest the genetic variations could eventually help researchers design more effective chemotherapeutic agents for pediatric ALL.

The company plans this year to add new markers to its HERmark breast cancer test, and will try to ink more collaborations with drug makers in order to embed its VeraTag assays in cancer drug trials.

The companies have signed a co-marketing and development pact for toxicity screenign tools and a personalized medicine pact.

The partners intend to sequence 1,000 genomes of people with cancer and create a compendium of cancer genome information.

Snippets: Feb 25, 2009

Premium

Myriad Genetics, Kinaxo Biotechnologies, Bavarian Research Foundation, European Commission, Decode Genetics, Ontario Institute for Cancer Research

The Quest For Function

Premium

Small RNA research continues to heat up as scientists deploy experimental and new computational tools to elucidate function. Plus, a peek at new findings in snoRNAs and moRs.

Already, the promise of synthetic biology is being realized as this level of engineering is brought into drug development. GT looks into synthetic biology drugs in the pipeline and where this field is heading.

Direct-to-consumer genetic testing companies have based their products on what scientists have accomplished, but the caveat is that the science is still in its early days.

Quest plans to develop and sell a diagnostic for prostate cancer based on the biomarker.

Taking vitamin E, selenium, or both for several weeks before having a prostatectomy can alter gene expression in prostate cancer biopsy samples.

Sequencing

Microarrays

According to a recent Bioinformatics paper, for each individual array, the proposed reference alignment procedure, or RAP, uses a set of selected markers as internal references to direct the signal alignment.

An international research team suggests high-resolution melting analysis is a useful tool for assessing DNA methylation in fixed tissue samples.

Pages

In PLOS this week: transcriptomic and genomic analysis of prostate cancer by ancestry, genes linked to liver function in Korean cohort, and more.

British Columbia is incorporating genomics into its tracking of the ongoing COVID-19 outbreak, Business in Vancouver reports.

An analysis by the Personalized Medicine Coalition finds that about a quarter of new drugs approved in 2019 by the US Food and Drug Administration were personalized medicines.

The governor of New York has proposed a five-year plan to study the genomes of people with or who are at high risk of developing Alzheimer's disease.